CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 26.70
-0.46 (-1.69%)
Nov 11, 2026, 4:08 PM HKT
CanSino Biologics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, CanSino Biologics stock has a consensus rating of "Strong Buy" and an average price target of $42.86. The average 1-year stock price forecast is 60.52% higher than the current stock price, while the lowest is $37.95 (+42.13%) and the highest is $46.03 (+72.40%).
Price Target: $42.86 (+60.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CanSino Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $53.20 → $46.10 | Buy | Maintains | $53.20 → $46.10 | +72.66% | Oct 29, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $43.00 | Buy | Maintains | $43.00 | +61.05% | Oct 28, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $46.00 | Buy | Maintains | $46.00 | +72.28% | Sep 8, 2026 |
Financial Forecast
Revenue This Year
1.42B
from 1.07B
Increased by 33.20%
Revenue Next Year
1.77B
from 1.42B
Increased by 24.38%
EPS This Year
0.45
from 0.16
Increased by 177.37%
EPS Next Year
1.66
from 0.45
Increased by 265.73%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.